SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-022556
Filing Date
2021-11-09
Accepted
2021-11-09 16:23:02
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20210930.htm   iXBRL 10-Q 1156321
2 EX-31.1 fhtx-20210930xex311.htm EX-31.1 9830
3 EX-31.2 fhtx-20210930xex312.htm EX-31.2 9809
4 EX-32.1 fhtx-20210930xex321.htm EX-32.1 4399
5 EX-32.2 fhtx-20210930xex322.htm EX-32.2 4384
  Complete submission text file 0001628280-21-022556.txt   5388480

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20210930.xsd EX-101.SCH 38512
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20210930_cal.xml EX-101.CAL 68572
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20210930_def.xml EX-101.DEF 149984
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20210930_lab.xml EX-101.LAB 484205
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20210930_pre.xml EX-101.PRE 295537
11 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20210930_htm.xml XML 867149
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 211392545
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences